Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.1 USD | -0.40% | -5.71% | +46.92% |
Mar. 21 | Adverum Biotechnologies Files $200 Million Mixed Shelf | MT |
Mar. 19 | RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 231M |
---|---|---|---|---|---|
Net income 2024 * | -111M | Net income 2025 * | -143M | EV / Sales 2024 * | - |
Net cash position 2024 * | 149M | Net cash position 2025 * | 136M | EV / Sales 2025 * | 9.59 x |
P/E ratio 2024 * |
-2.06
x | P/E ratio 2025 * |
-1.95
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Adverum Biotechnologies, Inc.
1 day | -1.76% | ||
1 week | -6.85% | ||
Current month | -21.15% | ||
1 month | -37.01% | ||
3 months | +31.19% | ||
6 months | +10.40% | ||
Current year | +48.11% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 22-12-11 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-04-15 | |
Clarence Machado
CHM | Chairman | 60 | 17-03-13 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 20-06-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 11.06 | -0.81% | 9 737 |
24-04-18 | 11.15 | -1.76% | 103,598 |
24-04-17 | 11.35 | -2.24% | 67,952 |
24-04-16 | 11.61 | +0.69% | 60,857 |
24-04-15 | 11.53 | -1.71% | 99,363 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.11% | 231M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.43% | 21.66B | |
-18.35% | 20.77B | |
-8.72% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- ADVM Stock